Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance
Go back to Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance| (NASDAQ: TARS) | Delayed: 63.16 +0.61 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.55 | 52 Week High | $ | |||
| Open | $63.38 | 52 Week Low | $ | |||
| Day High | $64.24 | P/E | N/A | |||
| Day Low | $62.37 | EPS | $ | |||
| Volume | 402,143 | |||||

